European Journal of Gynaecological Oncology
Print ISSN: 0392-2936 | Online ISSN: 2709-0086
European Journal of Gynaecological Oncology (EJGO) is an international, peer-reviewed, open access journal. EJGO publishes on a broad range of gynaecologic oncology topics. Different types of articles are considered for publication (see Aims & Scope) with emphasis on original research to include prospective clinical trials, basic and applied science, case-control, and cohort studies. We also encouraged the submission of systematic reviews and meta-analyses.
Articles
Effectiveness of manual lymphatic drainage for breast cancer-related lymphoedema: an overview of systematic reviews and meta-analyses
Effectiveness of manual lymphatic drainage for breast cancer-related lymphoedema: an overview of systematic reviews and meta-analyses
DOI: 10.22514/ejgo.2023.001
Timing and duration of bevacizumab treatment and survival in patients with recurrent ovarian, fallopian tube, and peritoneal cancer: a multi-institution study
Timing and duration of bevacizumab treatment and survival in patients with recurrent ovarian, fallopian tube, and peritoneal cancer: a multi-institution study
DOI: 10.22514/ejgo.2023.002
Effectiveness of neoadjuvant chemotherapy followed by radical surgery in young patients with locally advanced cervical cancer
Effectiveness of neoadjuvant chemotherapy followed by radical surgery in young patients with locally advanced cervical cancer
DOI: 10.22514/ejgo.2023.003
Effect of primary radiotherapy on the survival rate of stage IVB cervical cancer patients and factors related to their survival: a real-world study based on SEER database
Effect of primary radiotherapy on the survival rate of stage IVB cervical cancer patients and factors related to their survival: a real-world study based on SEER database
DOI: 10.22514/ejgo.2023.005
Development of mental health disorders in endometrial cancer survivors and the impact on overall survival—a population-based cohort study
Development of mental health disorders in endometrial cancer survivors and the impact on overall survival—a population-based cohort study
DOI: 10.22514/ejgo.2023.006
Clinical application of greater omentum plasty and fixation to prevent lymphocysts after lymphadenectomy in early-stage cervical cancer
Clinical application of greater omentum plasty and fixation to prevent lymphocysts after lymphadenectomy in early-stage cervical cancer
DOI: 10.22514/ejgo.2023.007
Quantitative evaluation of myelosuppression after chemotherapy for patients with ovarian cancer using material decomposition in dual-energy computed tomography
Quantitative evaluation of myelosuppression after chemotherapy for patients with ovarian cancer using material decomposition in dual-energy computed tomography
DOI: 10.22514/ejgo.2023.009
TfR associated with cervical cancer with or without neoadjuvant chemotherapy
TfR associated with cervical cancer with or without neoadjuvant chemotherapy
DOI: 10.22514/ejgo.2023.010
Evaluation on the efficacy of nursing intervention based on the self-efficacy theory model in elderly patients undergoing total laparoscopic hysterectomy
Evaluation on the efficacy of nursing intervention based on the self-efficacy theory model in elderly patients undergoing total laparoscopic hysterectomy
DOI: 10.22514/ejgo.2023.011
GLUT1-mediated magnetic liposomes for targeting bone metastatic breast cancer
GLUT1-mediated magnetic liposomes for targeting bone metastatic breast cancer
DOI: 10.22514/ejgo.2023.012
CENPF facilitates endometrial cancer cell progression through PI3K/AKT/mTOR pathway
CENPF facilitates endometrial cancer cell progression through PI3K/AKT/mTOR pathway
DOI: 10.22514/ejgo.2023.013
Endometrioid carcinoma associated with ovarian endometriosis: need for cautions during treatment
Endometrioid carcinoma associated with ovarian endometriosis: need for cautions during treatment
DOI: 10.22514/ejgo.2023.014
Tapeworm infection and secondary hemorrhagic shock found after cervical cancer surgery: a case report
Tapeworm infection and secondary hemorrhagic shock found after cervical cancer surgery: a case report
DOI: 10.22514/ejgo.2023.015
Published Ahead of Print
Special Issues
Topic Collection "Current Novel Treatment of Patients with Ovarian Cancer"
Keywords: Ovarian Cancer, Epithelial Ovarian Cancer, Optimal Debulking Surgery, Chemotherapy HIPEC, Platinum-resistant Ovarian Cancer, Anti-angiogenesis, PARP Inhibitors
Editor: Samir A. Farghaly, MD, PhD,Scott M. Eisenkop, MD
Submission deadline: 31 December 2022
Breast Cancer
Keywords: Breast cancer;Systemic treatment;Adjuvant setting;Metastatic setting;Genetic councelling;Triple negative breast cancer;Her2+ Breast cancer;Endocrine treatment
Editor: Michael Friedrich, MD,Nicolò Bertozzi, MD
Submission deadline: 30 April 2022
Systematic Review or Meta-Analysis in Gynaecological Oncology
Keywords: Cervical cancer;Ovarian cancer;Uterine/endometrial cancer;Vulvar cancer;Vaginal cancer;Breast cancer;Gestational trophoblastic disease;Primary peritoneal cancer
Editor: Enrique Hernandez, MD
Submission deadline: 25 April 2022
Gynecological Cancer Prevention: A New Prospective
Keywords: Gynecology; Obstetric and Gynecological Ultrasound; Menopause Obstetrics; Gynecologic Oncology; Gynecologic Pathology
Editor: Ottavia Dʼoria, MD
Submission deadline: 31 October 2023
Molecular Pathological Approach to Uterine Mesenchymal Tumors and Malignant Tumors for the Establishment of New Diagnostic and Therapeutic Methods
Keywords: Leiomyoma; Leiomyosarcoma; Ovarian cancer; Cervical cancer; Endometrial cancer
Editor: Prof. Takuma Hayashi
Submission deadline: 31 October 2023
Advanced Decision Support Systems for Efficient Diagnosis of Gynaecological Cancers
Keywords: Computational and Mathematical Methods; Gynaecological Cancers; Machine Learning; Optimization Algorithms
Editor: Liaqat Ali, PhD
Submission deadline: 31 October 2022
Polycystic Ovary Syndrome and the Risk of Endometrial Cancer
Keywords: PCOS; Endometrial Hyperplasia; Endometrial Cancer; Unopposed Estrogen Effect; Progesterone Resistance; Endometrial Mesenchymal Stroma/Stem Cells; Obesity; Insulin Resistance; Hyperandrogenism; Inflammation
Editor: Masuma Khatun, PhD
Submission deadline: 24 June 2023
The Management of Endometrial Cancer
Keywords: Endometrial Cancer; High-risk Factors; Adjuvant Treatment; Endocrine Therapy; Targeted Therapy
Editor: Nicolae Gica, MD, PhD,Yoland Antill, BMed FRACP MD
Submission deadline: 31 July 2023
Molecular Characterization in Endometrial Cancer: Progress and Prospects
Keywords: Endometrial Cancer (EC); Molecular Biomarkers; Immune Checkpoint Inhibitor; Precision Medicine
Editor: Andrea Giannini, MD, PhD
Submission deadline: 31 December 2022
Immunotherapy for Gynecological Oncology
Keywords: Cancer immunotherapy;Cancer vaccination;Immune checkpoint inhibitor;Ovarian cancer;Cervical cancer;Endometrial cancer
Editor: Tadahiro Shoji, MD
Submission deadline: 31 July 2021
Featured Article
Real-world bevacizumab utilization and outcomes among women with ovarian cancer in Europe and the United States. DOI: 10.31083/j.ejgo4206181
To Be a Reviewer
If you would like to volunteer to review a manuscript for European Journal of Gynaecological Oncology journal, please click “Review for EJGO” below to register at our submission website or log in our Online Peer Review system. Your name, contact details, and expertise will be automatically added to our database of reviewers.
Review for EJGOJoin Editorial Board
You are welcome to join our editorial board. Our journal produces and issues editorial board certificates for editorial board members, and the journal website will display the names and personal websites of editorial board members to help enhance their scientific influence. Members of the editorial committee are entitled to 1 free publication (both editorial member’s or recommended paper) per year, and other articles over 2 can enjoy 30% discount of publishing fee.
Join Editorial BoardEditor-in-Chief
Prof. Enrique Hernandez, MD, FACOG, FACS.
Dr. Hernandez is the J. Robert Willson Professor and Chair, Obstetrics, Gynecology and Reproductive Sciences of Lewis Katz School of Medicine at Temple University. He is also a professor in Pathology and Laboratory Medicine of Lewis Katz School of Medicine at Temple University. He specializes in comprehensive, compassionate care of women with gynecologic cancer and pre-cancerous conditions, using the most up-to-date and sophisticated diagnostic and treatment tools.